Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [6141]

ESTRO: Six months hormonal treatment in addition to radiotherapy improves survival for men with localised prostate cancer

ESTRO: Six months hormonal treatment in addition to radiotherapy improves survival for men with localised prostate...

AACR: First-in-class cancer metabolism drug AG-221 shows clinical activity in advanced blood cancers

AACR: First-in-class cancer metabolism drug AG-221 shows clinical activity in advanced blood cancers

AACR: New drug demonstrates early promise in metastatic breast cancer

AACR: New drug demonstrates early promise in metastatic breast cancer

ESTRO: Helium ions may provide superior, better-targeted treatment in paediatric radiotherapy

ESTRO: Helium ions may provide superior, better-targeted treatment in paediatric radiotherapy

World-first clinical trial launches for advanced bowel cancer

World-first clinical trial launches for advanced bowel cancer

Largest ever melanoma study demonstrates tolerability and efficacy of vemurafenib in most aggressive form of skin cancer

Largest ever melanoma study demonstrates tolerability and efficacy of vemurafenib in most aggressive form of skin...

ASCO report on US cancer care: Patient access threatened by growing demand and physician shortages

ASCO report on US cancer care: Patient access threatened by growing demand and physician shortages

Biosimilars set to change European oncology landscape

Biosimilars set to change European oncology landscape

EU rules are denying children latest cancer drugs, ICR claims

EU rules are denying children latest cancer drugs, ICR claims

Global cancer burden rises to 14.1 million new cases in 2012: Marked increase in breast cancers must be addressed

Global cancer burden rises to 14.1 million new cases in 2012: Marked increase in breast cancers must be addressed

More from ecancer